Based on a survey of cardiologist and pulmonologists treating patients for pulmonary arterial hypertension (PAH), analysts at ...

In a report released yesterday, Puneet Souda from Leerink Partners maintained a Hold rating on Myriad Genetics (MYGN – Research Report), with a ...

Leerink Partners analyst Puneet Souda maintained a Buy rating on Hologic (HOLX – Research Report) yesterday and set a price target of $80.00.

Leerink Partnrs boosted their FY2024 earnings per share (EPS) estimates for CRISPR Therapeutics in a note issued to investors ...

Stock analysts at Leerink Partnrs lifted their Q4 2025 earnings per share (EPS) estimates for shares of Illumina in a ...

TNYA Stock Performance and Moving Averages. In recent trading, Tenaya Therapeutics Inc (TNYA) stock price has shown some volatility, fluctuating -12.95% over the last five trades ...

Compass Therapeutics Inc. (CMPX) stock saw a decline, ending the day at $2.65 which represents a decrease of $-0.45 or -14.52% from the prior close of $3.1. The stock opened at $3.08 and touched a low ...

Less than a day into his second term, President Donald Trump ordered a freeze on communications at major public health ...

An experimental drug called amycretin showed signs it could be more potent than Eli Lilly’s rival Zepbound, though analysts ...

During his presentation at the J.P. Morgan Healthcare Conference last week, Incyte CEO Hervé Hoppenot took investors on a ...

CEO Joaquin Duato said the company is positioned for sustained growth in coming years even as competition batters Stelara, ...

Jefferies, Leerink Partners, Stifel and Cantor are acting as joint book-running managers for the proposed offering. The securities described above are being offered by Disc pursuant to an ...